Press Releases September 8, 2026 05:00 PM

Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference

Prestige Consumer Healthcare to participate in Barclays Global Consumer Conference

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
PBH

Prestige Consumer Healthcare Inc. announced that its CEO and CFO will participate in a fireside chat at the Barclays Global Consumer Conference. The event will be webcast live and later available for replay. Prestige is a leading consumer healthcare company with a diverse portfolio of well-known brands.

Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference
PBH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Prestige executives to engage with investors at a prominent global consumer conference, highlighting company strategy and outlook.
  • Live webcast and replay availability increases accessibility to investors and analysts.
  • Prestige's broad portfolio spans multiple consumer healthcare categories impacting retail and pharmaceutical sectors.

TARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, September 10, 2026 at 12:45 p.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:

https://ir.prestigebrands.com/events-presentations/events

For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the event.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. (NYSE: PBH) is a leading consumer healthcare company growing trusted, category-defining brands. Headquartered in New York, the Company markets, sells, manufactures and distributes its products across the U.S., Canada, Australia, and select other international markets. Its diverse portfolio of iconic brands includes Breathe Right®, Monistat®, Summer's Eve®, BC®, Goody's®, Dramamine®, Fleet®, Hydralyte®, Gaviscon®, DenTek®, TheraTears®, Clear Eyes®, Compound W®, Dermal Therapy®, Chloraseptic®, Luden's®, Little Remedies®, Boudreaux's Butt Paste®, Nix®, and Debrox®, among others. Learn more at www.prestigeconsumerhealthcare.com.

This press release was published by a CLEAR® Verified individual.


Risks

  • The conference presentation may not meet investor expectations, potentially limiting positive market impact.
  • Broader market or sector conditions could overshadow company-specific news despite the presentation.
  • Global supply chain or regulatory challenges impacting consumer healthcare products could affect future performance.

More from Press Releases

17 Education & Technology Group Inc. Announces Second Quarter 2026 Unaudited Financial Results Sep 8, 2026 Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Sep 8, 2026 MYR Group Inc. to Attend KeyBanc Taking Charge: Energy Transition Symposium in September Sep 8, 2026 Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference Sep 8, 2026 Constellation Brands Announces Delivery of Notice of Redemption for 4.350% Senior Notes Due 2027 Sep 8, 2026